166 related articles for article (PubMed ID: 2406869)
1. Animal model system for studying virulence of and host response to Bacteroides fragilis.
Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
[TBL] [Abstract][Full Text] [Related]
2. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
[TBL] [Abstract][Full Text] [Related]
3. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
Kasper DL; Onderdonk AB
Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
[TBL] [Abstract][Full Text] [Related]
4. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
[TBL] [Abstract][Full Text] [Related]
5. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
[TBL] [Abstract][Full Text] [Related]
6. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.
Crabb JH; Finberg R; Onderdonk AB; Kasper DL
Rev Infect Dis; 1990; 12 Suppl 2():S178-84. PubMed ID: 2406870
[TBL] [Abstract][Full Text] [Related]
7. Virulence factors in Bacteroides fragilis group.
Jotwani R; Gupta U
Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
[TBL] [Abstract][Full Text] [Related]
8. Surface antigens as virulence factors in infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
Jotwani R; Gupta U; Watanabe K; Ueno K
Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
[TBL] [Abstract][Full Text] [Related]
10. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
Simon GL; Klempner MS; Kasper DL; Gorbach SL
J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
[TBL] [Abstract][Full Text] [Related]
11. Immune mechanisms in the prevention of intra-abdominal abscess formation.
Kasper DL; Finberg RF; Crabb J; Onderdonk AB
Scand J Infect Dis Suppl; 1989; 62():29-34. PubMed ID: 2587962
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
Lindberg AA; Weintraub A
Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
[TBL] [Abstract][Full Text] [Related]
13. Role of T lymphocytes in liver abscess formation by Bacteroides fragilis in mice.
Chung DR; Park HR; Park CG; Hwang ES; Cha CY
Infect Immun; 2011 Jun; 79(6):2234-40. PubMed ID: 21444668
[TBL] [Abstract][Full Text] [Related]
14. The
Parker AC; Bergonia HA; Seals NL; Baccanale CL; Rocha ER
Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32457103
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
[TBL] [Abstract][Full Text] [Related]
16. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity of the Bacteroides fragilis group.
Brook I
Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
[TBL] [Abstract][Full Text] [Related]
18. The Bacteroides fragilis pathogenicity island links virulence and strain competition.
Casterline BW; Hecht AL; Choi VM; Bubeck Wardenburg J
Gut Microbes; 2017 Jul; 8(4):374-383. PubMed ID: 28632016
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
[TBL] [Abstract][Full Text] [Related]
20. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
